Developer of novel drugs intended to treat central nervous system disorders and challenging bacterial infections. The company's drug design platform identifies new therapies for rare disorders of the central nervous system and multidrug-resistant gram-negative bacterial infections.
1
Funding Rounds
Access comprehensive data and insights available only to Seedtable members
Trusted by investors, founders, and analysts worldwide
Access detailed insights on 71,000+ companies worldwide